NIFEdipine Capsules USP — Class III drug recall D-0143-2017
Terminated recall by Actavis Elizabeth LLC, reported 2016-11-30. Presence of Foreign Tablets/Capsules
| Recall number | D-0143-2017 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Actavis Elizabeth LLC, Elizabeth, NJ, United States |
| Recall initiated | 2016-10-06 |
| Classified | 2016-11-18 |
| Reported by FDA | 2016-11-30 |
| Terminated | 2017-05-08 |
| Quantity | 27,517 bottles |
| NDC | 00228-2407-10 |
| Lot numbers | 03/18, 0598B151 |
Product
NIFEdipine Capsules USP, 10 mg, Rx only, 100 count bottle, Manufactured and distributed by: Actavis Elizabeth LLC, 200 Elmora Avenue, Elizabeth, NJ 07207, NDC 0228-2407-10
Reason for recall
Presence of Foreign Tablets/Capsules
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0143-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.